Document Detail


Insulin analogues in the management of the pregnancy complicated by diabetes mellitus.
MedLine Citation:
PMID:  21072620     Owner:  NLM     Status:  In-Process    
Abstract/OtherAbstract:
Since their introduction, insulin analogues are the preferred choice for short-acting insulin due to their superior pharmacologic profiles, leading to greater flexibility and convenience of dosing and, thus, greater patient satisfaction and improved quality of life. Over the past few years, clinical experience with insulin analogues in pregnancy has increased. The most studied, insulin lispro, has been shown to be a safe and clinically effective option in the treatment of the diabetic gravida. Studies of the other insulin analogues are limited, but promising. Further research is warranted to evaluate safety and efficacy of these analogues.
Authors:
Celeste P Durnwald; Mark B Landon
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current diabetes reports     Volume:  11     ISSN:  1539-0829     ISO Abbreviation:  Curr. Diab. Rep.     Publication Date:  2011 Feb 
Date Detail:
Created Date:  2011-01-11     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101093791     Medline TA:  Curr Diab Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  28-34     Citation Subset:  IM    
Affiliation:
Department of Obstetrics and Gynecology, The Ohio State University, 395 West 12th Avenue, Columbus, OH 43210, USA. celeste.durnwald@osumc.edu
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Relaxin-3/INSL7 Regulates the Stress-response System in the Rat Hypothalamus.
Next Document:  Objective assessment of dermatitis following post-operative radiotherapy in patients with breast can...